Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma.
Hsu CL, Lui KW, Chi LM, Kuo YC, Chao YK, Yeh CN, Lee LY, Huang Y, Lin TL, Huang MY, Lai YR, Yeh YM, Fan HC, Lin AC, Lu YJ, Hsieh CH, Chang KP, Tsang NM, Wang HM, Chang AY, Chang YS, Li HP.
Hsu CL, et al. Among authors: lu yj.
J Exp Clin Cancer Res. 2018 Sep 20;37(1):233. doi: 10.1186/s13046-018-0873-5.
J Exp Clin Cancer Res. 2018.
PMID: 30236142
Free PMC article.